Skip to main content
Filing year 2021

CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION

Birmingham, Alabama·EIN 26-1990525·NTEE G03 · Diseases, Disorders & Medical Disciplines·501(c)(3)
Total revenue
$15k
Total assets
$69k
Total expenses
$3k
Reported officers
11

Reported officers (all unpaid)

No paid executives reported in 2021. CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION reported 11 unpaid officers and board members on its 990-EZ.

President
Vice-president
Treasurer
Secretary
Board Member
Board Member
Board Member
Board Member
Board Member
Board Member
Board Member
Sector benchmark

What Diseases, Disorders & Medical Disciplines executives earn

CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable diseases, disorders & medical disciplines organization nationwide earns a median of $91,250.

25th percentile
$43k
Median
$91,250
75th percentile
$169k
90th percentile
$325k

These are diseases, disorders & medical disciplines sector-wide figures, not this organization's reported pay. Based on 2,397 organizations across 2,397 filings (2021 – 2024).

See full Diseases, Disorders & Medical Disciplines compensation data
FAQ

Common questions about CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION

What are CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION's revenue and expenses?

In 2021, CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION reported $15k in total revenue and $3k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.